Perguntar
Consultar
Descobrir
Calcular
Cadastre-se
Cadastre-se
Entrar
Entrar
Descobrir
FDA Approval of Gazyva (Obinutuzumab) for Active Lupus Nephritis: Superiority Over Standard Therapy Demonstrated in Phase III REGENCY Trial - Notícias Vera Health